N1,N3-disubstituted uracils as nonnucleoside inhibitors of HIV-1 reverse transcriptase

Bioorganic & Medicinal Chemistry
2013.0

Abstract

A series of phenyloxyethyl and cinnamyl derivatives of substituted uracils were synthesized and found to exhibit potent activity against HIV-RT and HIV replication in cell culture. In general, the cinnamyl derivatives proved superior to the phenyloxyethyl derivatives, however 1-[2-(4-methylphenoxy)ethyl]-3-(3,5-dimethylbenzyl)uracil (19) exhibited the highest activity (EC(50)=0.27 μM) thus confirming that the 3-benzyluracil fragment in the NNRTI structure can be regarded as a functional analogue of the benzophenone pharmacophore typically found in NNRTIs.

Knowledge Graph

Similar Paper

N1,N3-disubstituted uracils as nonnucleoside inhibitors of HIV-1 reverse transcriptase
Bioorganic & Medicinal Chemistry 2013.0
1-[2-(2-Benzoyl- and 2-benzylphenoxy)ethyl]uracils as potent anti-HIV-1 agents
Bioorganic & Medicinal Chemistry 2011.0
Synthesis and evaluation of novel 3-(3,5-dimethylbenzyl)uracil analogs as potential anti-HIV-1 agents
Bioorganic & Medicinal Chemistry 2013.0
Structure-activity evaluation of new uracil-based non-nucleoside inhibitors of HIV reverse transcriptase
MedChemComm 2013.0
1,6-Bis[(benzyloxy)methyl]uracil derivatives—Novel antivirals with activity against HIV-1 and influenza H1N1 virus
Bioorganic & Medicinal Chemistry 2016.0
Scaffold hopping: Exploration of acetanilide-containing uracil analogues as potential NNRTIs
Bioorganic & Medicinal Chemistry 2015.0
Synthesis and biological activity of naphthyl-substituted (B-ring) benzophenone derivatives as novel non-nucleoside HIV-1 reverse transcriptase inhibitors
Bioorganic & Medicinal Chemistry 2011.0
Benzophenone Derivatives: A Novel Series of Potent and Selective Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase
Journal of Medicinal Chemistry 1995.0
Novel N1-substituted 1,3-dihydro-2H-benzimidazol-2-ones as potent non-nucleoside reverse transcriptase inhibitors
Bioorganic & Medicinal Chemistry 2008.0
Design, Synthesis, and Biological Evaluation of 1-[(2-Benzyloxyl/alkoxyl)methyl]-5-halo-6-aryluracils as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with an Improved Drug Resistance Profile
Journal of Medicinal Chemistry 2012.0